Gangolli Julian S 4
4 · Krystal Biotech, Inc. · Filed Jul 3, 2023
Insider Transaction Report
Form 4
Gangolli Julian S
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-30+6,800→ 6,800 totalExercise: $117.40Exp: 2033-06-30→ Common Stock (6,800 underlying)
Footnotes (1)
- [F1]The options were awarded on June 30, 2023 and vest in equal monthly tranches over a one-year period.